Eli Lilly And Company / Lilly Deutschland Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Eli Lilly And Company / Lilly Deutschland Gmbh

Patent Number:
Title:
Il-17 A/F Heterologous Polypeptides And Therapeutics Uses Thereof
Applicant:
Opposition Date:
Mar 16, 2020

Competitors of Eli Lilly And Company / Lilly Deutschland Gmbh

GENENTECH, INC.

NOVARTIS PHARMA AG

Want to track Eli Lilly And Company / Lilly Deutschland Gmbh?

Feel free to send us a message here and we will get back to you